Isomorphic Labs appoints Dr. Ben Wolf as Chief Medical Officer and establishes US Presence

Contributed by: PR Newswire

Tags

Isomorphic-Labs

More Like This

Isomorphic Labs announces $600 million funding to further develop its next-generation AI drug design engine and advance therapeutic programs into the clinic

ISOMORPHIC LABS ANNOUNCES STRATEGIC MULTI-TARGET RESEARCH COLLABORATION WITH NOVARTIS

ISOMORPHIC LABS ANNOUNCES STRATEGIC MULTI-TARGET RESEARCH COLLABORATION WITH LILLY

PR Newswire associated0

GenBio AI Expands Global Leadership with Ziv Bar-Joseph as Co-Founder and Chief Scientific Officer

Business Wire logo

BenevolentAI Appoints Kenneth Mulvany as Executive Chairman

BenevolentAI CEO to Join Panel at Morgan Stanley 3rd Annual Life Sciences AI Summit

Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today that Dr. Alastair Leighton has joined as Chief Operating Officer (COO). With almost three decades in the biopharma industry working at leading global pharmaceutical companies, Dr. Leighton brings a wealth of experience in manufacturing, supply chain operations and commercial strategy. (Photo: Business Wire)

Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer

BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer